- AdventHealth Research Institute
For decades, Type 1 diabetes (T1D) was perceived as a condition that appeared suddenly, transforming a person's life overnight. However, recent research is uncovering a different reality. Scientists have found that T1D develops gradually, often over several years, as the body's immune system begins to attack the insulin-producing cells in the pancreas. This important discovery has paved the way for an extraordinary possibility: the potential for prevention.
At AdventHealth’s Translational Research Institute (TRI) and centers across the country, researchers, scientists, and clinicians are studying ways to identify T1D before symptoms even appear. Through simple blood tests that look for autoantibodies, markers that show the immune system is active against insulin-producing cells, researchers can now detect the earliest signs of the disease, sometimes years before diagnosis.
This early detection means intervention is finally possible. Ongoing studies are exploring new treatments that could protect the pancreas, slow the immune attack, or even stop it entirely. It’s a radical shift moving from waiting to treat diabetes after it develops to finding ways to keep it from starting at all.
For families, that message brings hope. For those who already live with T1D, it means a future where children and grandchildren might never have to face it. For those at risk, it means having time to prepare, monitor, and participate in prevention studies that could make a lasting difference.
What You Can Do This Diabetes Awareness Month
1. Learn your risk.
If someone in your family has T1D, you can get screened for diabetes-related autoantibodies. These tests can reveal your risk level long before symptoms begin.
2. Pay attention to symptoms.
Excessive thirst, frequent urination, fatigue, or unexpected weight loss can all be early signs of diabetes. If you or your child experiences these, see a healthcare provider right away.
3. Support research.
Clinical studies rely on volunteers, both those with and without diabetes, to advance prevention and treatment. Participating or donating helps fuel discoveries that bring us closer to a world without T1D.
4. Share what you learn.
Awareness starts with conversation. Sharing accurate information about prevention and early testing could help someone you know detect diabetes before it becomes dangerous.
Prevention is no longer a far-off dream. Scientists are learning how to recognize T1D before it takes hold, and families are stepping up to be part of that change. Every test, every trial, every conversation brings us closer to a future where T1D may never have a chance to begin.
Recent News
Clinical Trial Evidence on Diet and Type 1 Diabetes Outcomes
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes.
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.
AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial
On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.
MANIFEST US Study Presented as a Late-Breaking Clinical Trial at AHA
The cardiovascular team is excited to highlight the MANIFEST US study, which was presented on November 10th as a Late-Breaking Clinical Trial at the American Heart Association (AHA) Scientific...
Nourishing Your Gut: Dr. Karen Corbin on the Power of Fiber
Dr. Karen Corbin, associate investigator at the AdventHealth Translational Research Institute for Metabolism and Diabetes in Orlando, emphasizes the essential role of diet in maintaining a healthy gut...
Southeast Region – Redmond Campus: AdventHealth Recognized as Top Enroller Nationally for the CARVTOP-ICD Trial
AdventHealth Research Institute (AHRI) is proud to announce that the Southeast Region’s Redmond Campus has been recognized as the top enrolling site nationally for the CARVTOP-ICD trial.
Stiff Arteries Linked to Early Memory Decline: New Findings by Dr. Amani Norling
Amani Norling, PhD a post-doctoral fellow at the AdventHealth Neuroscience institute, has published a notable paper titled “Arterial stiffness moderates the link between NfL and cognition: The IGNITE...
First BrioVAD Implant Successfully Completed
On September 24, the Transplant team successfully implanted the first BrioVAD device at AdventHealth, a major milestone in the ongoing INNOVATE 2254936 Vidic trial.
Advancing T1D Science: New TRI Publications
Researchers at the AdventHealth Translational Research Institute continue to drive meaningful progress in Type 1 diabetes—work that is being recognized not just in Central Florida, but throughout the...
The T1D Daily Reset: Small Habits With Big Impact
As we head into 2026, many people living with Type 1 diabetes are looking for ways to reset their routines and start the year feeling more balanced and in control.
Advancing Heart Care: A New Chapter with the BrioVAD Study
The AdventHealth Research team recently completed Core Training for the INNOVATE 2254936 Vidic trial, bringing this novel device to AdventHealth.